Professor Justin Stebbing
MD MA FRCP FRCPath PhD
Professor of Cancer Medicine and Oncology, Consultant Oncologist, Imperial College and Imperial College Healthcare NHS Trust.Professor Stebbing trained in medicine at Trinity College, University of Oxford. After completion of junior doctor posts in Oxford, he undertook training and a residency at The Johns Hopkins Hospital in the US, returning to London to continue his career in oncology at The Royal Marsden and St Bartholomew's Hospitals and now through Imperial College Healthcare NHS Trust.
Professor Stebbing has published over 500 peer-reviewed papers in journals such as the Lancet, New England Journal, Blood, the Journal of Clinical Oncology, Annals of Internal Medicine, as well as writing for national newspapers and presenting new data on optimal cancer therapies at major international conferences. His focus at Imperial is on new therapies in cancer, and the systemic management of patients with solid malignancies. His laboratory work is concentrated on new druggable target discovery.
He is a Fellow of the Royal College of Physicians, the American Board of Internal Medicine and the Royal College of Pathologists, and sits on the advisory Boards of a number of international cancer committees. He chairs the World Vaccine Congress and is on the editorial board of a number of world leading general medical and cancer journals such as the Journal of Clinical Oncology. In 2011, Justin's team published in Nature Medicine, outlining the groundbreaking discovery of a new cancer-causing gene and a totally new theory in cancer drug resistance. He was appointed the government's first oncology professor funded by the National Institute for Health Research (NIHR) – the mechanism the government uses to fund research through the NHS. In 2016 Justin was internationally recognised with his appointment as co-Editor-in-Chief of Oncogene (Nature Publishing Group's cancer journal) and election to the American Society for Clinical Investigation.
Action Against Cancer's important role
Finding something new, and looking at cancer in a new way, is hard - but we can do it. Action Against Cancer is enabling me and my team to do that, and to think differently, allowing calculated risks to be taken. Perhaps the biggest risk is not to take risks...Read more
"Justin Stebbing is the brightest young oncologist that I have come across; he has an incredible drive combined with extraordinary intelligence."
"Justin combines his passion for scientific discovery with his calling to do the utmost for his patients. His commitment to discovering the root causes of cancer and developing groundbreaking cancer therapies is truly remarkable."
"Professor Stebbing is a tireless and creative protagonist in the battle against cancer. Always open-minded and receptive to new ideas, he understands the complex dynamics involved in new drug development and has the intellectual courage and stamina to bring the fight to the enemy. He is a risk-taker, and we desperately need more like him."
"Professor Stebbing is not only an outstanding physician scientist but a very passionate clinician focused on the most innovative and cutting edge research. He is thinking outside the box and is an impressive and productive collaborator."